Omalizumab: as a tool
2 studies: an imaging tracer or a test of drug response. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)CompletedNCT00777764Phase 4Results postedHow we knowReport a problem
- Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema HerpeticumStatus unknownNCT04060550How we knowReport a problem